Literature DB >> 24339141

Osteocalcin is inversely associated with glucose levels in middle-aged Tibetan men with different degrees of glucose tolerance.

Xiang Chen1, Yunhong Wu, Lin Liu, Haoming Tian, Xijie Yu.   

Abstract

BACKGROUND: Research on the characteristics and mechanisms of diabetes in Tibetans is scant. Especially, there is no study on the relationship between osteocalcin and glucose metabolism. The objective of this study was to investigate the associations of serum total osteocalcin (tOC) and undercarboxylated osteocalcin (ucOC) with glucose and lipid metabolism in Chinese indigenous Tibetans with different degrees of glucose tolerance.
METHODS: In this study, 160 middle-aged Tibetan men were involved, including 46 subjects with normal glucose tolerance (NGT), 52 subjects with impaired glucose regulation (IGR) and 62 subjects with type 2 diabetes. The homeostasis model assessment (HOMA) parameters, including HOMA-IR and HOMA-B, were used to estimate insulin resistance and β-cell function, respectively. Adiponectin, leptin, testosterone, 1,25-dihydroxyvitamin D, tOC and ucOC were measured using ELISA kits.
RESULTS: After adjustment for age and body mass index, plasma tOC level was correlated negatively with fasting and 30-min post-OGTT glucose, HOMA-IR, leptin and testosterone; plasma ucOC level was correlated negatively with 30-min post-OGTT glucose, total cholesterol and 1,25-dihydroxyvitamin D; ucOC : tOC was correlated positively with leptin. The negative association between HOMA-IR and tOC remained significant after correcting for adiponectin; however, the association disappeared after correcting for leptin. HOMA-IR was correlated negatively with age, adiponectin and tOC, and positively with total cholesterol, triglyceride and leptin. Stepwise linear regression analysis revealed that total cholesterol, leptin and adiponectin were independent predictors for HOMA-IR in all subjects.
CONCLUSIONS: Our data support a link between osteocalcin and glucose metabolism in middle-aged Tibetan men. The improved glucose tolerance exerted by tOC may be related to improved insulin sensitivity rather than improved β-cell function.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Tibetan; glucose metabolism; insulin resistance; leptin; osteocalcin

Mesh:

Substances:

Year:  2014        PMID: 24339141     DOI: 10.1002/dmrr.2509

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

1.  The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: a double-blind randomized controlled clinical trial.

Authors:  H Rasekhi; M Karandish; M T Jalali; M Mohammad-Shahi; M Zarei; A Saki; H Shahbazian
Journal:  Eur J Clin Nutr       Date:  2015-03-18       Impact factor: 4.016

2.  Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics.

Authors:  Jianwen Wei; Stephen Flaherty; Gerard Karsenty
Journal:  Expert Rev Endocrinol Metab       Date:  2015-06-16

Review 3.  New insights into the biology of osteocalcin.

Authors:  Meredith L Zoch; Thomas L Clemens; Ryan C Riddle
Journal:  Bone       Date:  2015-06-06       Impact factor: 4.398

4.  Association between osteocalcin and glucose metabolism: a meta-analysis.

Authors:  D-M Liu; X-Z Guo; H-J Tong; B Tao; L-H Sun; H-Y Zhao; G Ning; J-M Liu
Journal:  Osteoporos Int       Date:  2015-06-19       Impact factor: 4.507

5.  Phylloquinone supplementation improves glycemic status independent of the effects of adiponectin levels in premonopause women with prediabetes: a double-blind randomized controlled clinical trial.

Authors:  Hamid Rasekhi; Majid Karandish; Mohammad-Taha Jalali; Majid Mohammadshahi; Mehdi Zarei; Azadeh Saki; Hajieh Shahbazian
Journal:  J Diabetes Metab Disord       Date:  2015-01-14

6.  GGCX and VKORC1 inhibit osteocalcin endocrine functions.

Authors:  Mathieu Ferron; Julie Lacombe; Amélie Germain; Franck Oury; Gérard Karsenty
Journal:  J Cell Biol       Date:  2015-03-09       Impact factor: 10.539

7.  Circulating osteocalcin is associated with time in range and other metrics assessed by continuous glucose monitoring in type 2 diabetes.

Authors:  Jun Liu; Yinghua Wei; Pu Zang; Wei Wang; Zhouqin Feng; Yanyu Yuan; Hui Zhou; Zhen Zhang; Haiyan Lei; Xinyi Yang; Jun Liu; Bin Lu; Jiaqing Shao
Journal:  Diabetol Metab Syndr       Date:  2022-08-04       Impact factor: 5.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.